Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

5-Aminothalidomide is a derivative of the immunomodulatory compound (±)-thalidomide (Item No. 14610). It inhibits the proliferation of EA.hy926 endothelial cells (IC50 = 200 µM).1 5-Aminothalidomide is an intermediate in the synthesis of a PROTAC c-MET degrader with antiproliferative activity in c-MET-sensitive EBC-1 and Hs 746T cancer cells.2 It is also an intermediate in the synthesis of a thalidomide derivative that reduces clinical scores in a mouse model of experimental autoimmune encephalomyelitis (EAE).1
WARNING This product is not for human or veterinary use.
1. Preliminary biological evaluations of new thalidomide analogues for multiple sclerosis application. Biooorg. Med. Chem. Lett. 19(3), 878-881 (2009).
2. Discovery of novel exceptionally potent and orally active c-